Friday, October 4, 2024
HomeLatest Pharma-NewsMerck to Present at the UBS Virtual Global Healthcare Conference

Merck to Present at the UBS Virtual Global Healthcare Conference

May 14, 2020: “Merck known as MSD outside the United States and Canada, announced that Mike Nally, executive vice president and chief marketing officer, is scheduled to participate in a fireside chat at the UBS Virtual Global Healthcare Conference on May 18, 2020, at 11:40 a.m. EDT.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://investors.merck.com/events-and-presentations/default.aspx.

- Advertisement -
Merck

For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.

For More News: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Use at an Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Adult Indications
Merck’s anti-PD-1 therapy KEYTRUDA(pembrolizumab) for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

https://www.mrknewsroom.com/news-release/corporate-news/merck-present-ubs-virtual-global-healthcare-conference

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular